Reprint of Classification and pharmacology of progestins

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA · 2002 · 15.8K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

Stephen B. Hulley · JAMA · 1998 · 6.3K citations

Medicine, Endocrinology, Pharmacotherapy +17

Breast cancer and hormone-replacement therapy in the Million Women Study

Valerie Beral · The Lancet · 2003 · 3K citations

Medicine, Endocrinology, Oncology +13

Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy

Deborah Grady, David Herrington, Vera Bittner et al. · JAMA · 2002 · 1.9K citations

Medicine, Cardiology, Endocrinology +17

Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. <i>JAMA</i> 2002; 288(3): 321-333

Dr Ailsa Gebbie · Journal of Family Planning and Reproductive Health Care · 2002 · 1.2K citations · Full text

Medicine, Endocrinology, Gynecology +11